Filing Details

Accession Number:
0000950170-24-081567
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-03 16:30:05
Reporting Period:
2024-07-01
Accepted Time:
2024-07-03 16:30:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1756262 Transmedics Group Inc. TMDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1430462 I Tamer Khayal C/O Transmedics Group, Inc.
200 Minuteman Road
Andover MA 01810
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-01 1,458 $38.46 22,301 No 4 M Direct
Common Stock Acquisiton 2024-07-01 417 $66.10 22,718 No 4 M Direct
Common Stock Acquisiton 2024-07-01 1,083 $13.28 23,801 No 4 M Direct
Common Stock Disposition 2024-07-01 110 $149.57 23,691 No 4 S Direct
Common Stock Disposition 2024-07-01 1,000 $150.70 22,691 No 4 S Direct
Common Stock Disposition 2024-07-01 1,106 $151.33 21,585 No 4 S Direct
Common Stock Disposition 2024-07-01 582 $152.53 21,003 No 4 S Direct
Common Stock Disposition 2024-07-01 160 $153.48 20,843 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-07-01 1,458 $0.00 1,458 $38.46
Common Stock Stock Option (Right to Buy) Disposition 2024-07-01 417 $0.00 417 $66.10
Common Stock Stock Option (Right to Buy) Disposition 2024-07-01 1,083 $0.00 1,083 $13.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,667 2031-02-24 No 4 M Direct
13,349 2033-02-20 No 4 M Direct
21,667 2032-02-22 No 4 M Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.00 to $149.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.00 to $150.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.00 to $151.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $152.00 to $152.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $153.04 to $153.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.
  8. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027.
  9. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.